- Home
- PTGX vs IEP Comparison
PTGX vs IEP Comparison
Compare PTGX & IEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | IEP |
|---|---|---|
| Founded | 2006 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.7B |
| IPO Year | 2016 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PTGX | IEP |
|---|---|---|
| Price | $105.55 | $8.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $108.23 | N/A |
| AVG Volume (30 Days) | 713.3K | ★ 763.6K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 25.84% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $9,658,000,000.00 |
| Revenue This Year | $873.97 | N/A |
| Revenue Next Year | N/A | $5.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $41.29 | $7.08 |
| 52 Week High | $107.84 | $9.99 |
Technical Indicators
Market Signals| Indicator | PTGX | IEP |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 64.57 |
| Support Level | $76.63 | $8.02 |
| Resistance Level | $107.84 | $8.29 |
| Average True Range (ATR) | 4.03 | 0.14 |
| MACD | -0.12 | 0.04 |
| Stochastic Oscillator | 84.57 | 95.31 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About IEP Icahn Enterprises L.P.
Icahn Enterprises LP provides diversified business services in the United States. The company operates its business through varied segments which include Investment, Automotive, Energy, Food Packaging, Real Estate, Pharma, and Home Fashion. Among these, the Energy segment derives the maximum revenue from the company. Geographically, it generates maximum revenue from the United States.